Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol

Authors

Joost Raaphorst (ORCID: https://orcid.org/0000-0002-3658-2001)
Robbert J Goekoop
Jan van Laar (ORCID: https://orcid.org/0000-0002-8885-4929)
Sander W. Tas (ORCID: https://orcid.org/0000-0002-8940-1788)
César Magro‐Checa (ORCID: https://orcid.org/0000-0002-5685-3091)
Jacob M. van Laar (ORCID: https://orcid.org/0000-0001-5544-5785)
Nicolle H. Rekers (ORCID: https://orcid.org/0000-0003-4172-151X)
Paco M J Welsing (ORCID: https://orcid.org/0000-0003-2361-2803)
Rogier M. Thurlings (ORCID: https://orcid.org/0000-0003-4054-0290)
Bettina C Geertsema-Hoeve (ORCID: https://orcid.org/0009-0002-4508-1812)
Erik Present

Institutions

Radboud University Nijmegen (NL)
Erasmus MC (NL)
Radboud University Medical Center (NL)
University Medical Center Utrecht (NL)
Alfasigma (Italy) (IT)
Zuyderland Medisch Centrum (NL)
Haga Hospital (NL)
University of Amsterdam (NL)
Erasmus University Rotterdam (NL)

Publication Details

Journal: BMJ Open
Published: 2025-02-01
DOI: https://doi.org/10.1136/bmjopen-2024-089827
Citations: 5
Primary Topic: IgG4-Related and Inflammatory Diseases
Type: article
Field-Weighted Citation Impact: 8.34

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol

Joost Raaphorst, Robbert J Goekoop, Jan van Laar, Sander W. Tas et al.

Feb 1, 2025

5 citations

BMJ Open

IgG4-Related and Inflammatory Diseases

8.34

article

Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol

Joost Raaphorst, Robbert J Goekoop, Jan van Laar, Sander W. Tas, César Magro‐Checa, Jacob M. van Laar, Nicolle H. Rekers, Paco M J Welsing, Rogier M. Thurlings, Bettina C Geertsema-Hoeve, Erik Present

February 1, 2025article en

5 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(2)

Radboud University Nijmegen (NL), Erasmus MC (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Alfasigma (Italy) (IT), Zuyderland Medisch Centrum (NL), Haga Hospital (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL)

Good health and well-being

Openalex Percentile: Top 3%

IgG4-Related and Inflammatory Diseases

8.34

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.